Aiello, Edoardo Nicolò
Verde, Federico
Solca, Federica
Milone, Ilaria
Giacopuzzi Grigoli, Eleonora
Dubini, Antonella
Ratti, Antonia
Ferrucci, Roberta
Torresani, Erminio
Priori, Alberto
Ticozzi, Nicola
Silani, Vincenzo
Poletti, Barbara http://orcid.org/0000-0003-4398-2051
Funding for this research was provided by:
Ministero della Salute
Article History
Received: 31 October 2022
Accepted: 22 January 2023
First Online: 27 January 2023
Declarations
:
: The participants provided informed consent. This study was approved by the Ethics Committee of IRCCS Istituto Auxologico Italiano (I.D.: 2021_05_18_04).
: V.S. received compensation for consulting services and/or speaking activities from AveXis, Cytokinetics, Italfarmaco, Liquidweb S.r.l., and Novartis Pharma AG, receives or has received research supports from the Italian Ministry of Health, AriSLA, and E-Rare Joint Transnational Call. He is in the Editorial <i>Board of Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration</i>, <i>European Neurology</i>, <i>American Journal of Neurodegenerative Diseases</i>, <i>Frontiers in Neurology</i>. B.P. received compensation for consulting services and/or speaking activities from Liquidweb S.r.l. She is an Associate Editor for <i>Frontiers in Neuroscience.</i> N.T. received compensation for consulting services from Amylyx Pharmaceuticals and Zambon Biotech SA. He is an Associate Editor for <i>Frontiers in Aging Neuroscience</i>. The other authors declare no competing interests.